{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:17Z","timestamp":1791999137914,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-025-00923-8","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:25:42Z","timestamp":1761283542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ACTG1 driven splicing of P4HB gene enhances EMT and bladder cancer progression"],"prefix":"10.1038","volume":"9","author":[{"given":"Zhenghua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"923_CR1","doi-asserted-by":"publisher","first-page":"859707","DOI":"10.3389\/fonc.2022.859707","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. CNN1 represses bladder cancer progression and metabolic reprogramming by modulating HIF-1\u03b1 signaling pathway. Front. Oncol. 12, 859707 (2022).","journal-title":"Front. Oncol."},{"key":"923_CR2","doi-asserted-by":"publisher","first-page":"825109","DOI":"10.3389\/fgene.2021.825109","volume":"12","author":"Q Liu","year":"2022","unstructured":"Liu, Q. Current advances in N6-methyladenosine methylation modification during bladder cancer. Front. Genet. 12, 825109 (2022).","journal-title":"Front. Genet."},{"key":"923_CR3","doi-asserted-by":"publisher","first-page":"5510663","DOI":"10.1155\/2021\/5510663","volume":"2021","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Pegylated recombinant human arginase 1 induces autophagy and apoptosis via the ROS-activated AKT\/mTOR pathway in bladder cancer cells. Oxid. Med. Cell. Longev. 2021, 5510663 (2021).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"923_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","volume":"4","author":"E Laukhtina","year":"2021","unstructured":"Laukhtina, E. et al. Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis. Eur. Urol. Oncol. 4, 927\u2013942 (2021).","journal-title":"Eur. Urol. Oncol."},{"key":"923_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","volume":"20","author":"M Maas","year":"2023","unstructured":"Maas, M. et al. Urine biomarkers in bladder cancer - current status and future perspectives. Nat. Rev. Urol. 20, 597\u2013614 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"923_CR6","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.33794","volume":"149","author":"H Lai","year":"2021","unstructured":"Lai, H. et al. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int. J. Cancer 149, 2099\u20132115 (2021).","journal-title":"Int. J. Cancer"},{"key":"923_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley, R. K. & Anczuk\u00f3w, O. RNA splicing dysregulation and the hallmarks of cancer. Nat. Rev. Cancer 23, 135\u2013155 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"923_CR8","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/biom11121850","volume":"11","author":"M Hassn Mesrati","year":"2021","unstructured":"Hassn Mesrati, M. et al. CD44: a multifunctional mediator of cancer progression. Biomolecules 11, 1850 (2021).","journal-title":"Biomolecules"},{"key":"923_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13046-020-01798-2","volume":"40","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Noncoding RNAs regulate alternative splicing in Cancer. J. Exp. Clin. Cancer Res. 40, 11 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"923_CR10","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/onc.2015.318","volume":"35","author":"A Sveen","year":"2016","unstructured":"Sveen, A. et al. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene 35, 2413\u20132427 (2016).","journal-title":"Oncogene"},{"key":"923_CR11","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.3390\/cancers14163854","volume":"14","author":"SL Kastora","year":"2022","unstructured":"Kastora, S. L. et al. Integrative, in silico and comparative analysis of breast cancer secretome highlights invasive-ductal-carcinoma-grade progression biomarkers. Cancers 14, 3854 (2022).","journal-title":"Cancers"},{"key":"923_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/RUQ.0000000000000678","volume":"40","author":"L Ren","year":"2024","unstructured":"Ren, L. et al. Ultrasound microbubble-stimulated miR-145-5p inhibits malignant behaviors of breast cancer cells by targeting ACTG1. Ultrasound Q. 40, 136\u2013143 (2024).","journal-title":"Ultrasound Q."},{"key":"923_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13046-021-02175-3","volume":"41","author":"F Qiu","year":"2022","unstructured":"Qiu, F. et al. Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation. J. Exp. Clin. Cancer Res. 41, 22 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"923_CR14","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.devcel.2021.11.006","volume":"56","author":"F L\u00fc\u00f6nd","year":"2021","unstructured":"L\u00fc\u00f6nd, F. et al. Distinct contributions of partial and full EMT to breast cancer malignancy. Dev. Cell 56, 3203\u20133221.e11 (2021).","journal-title":"Dev. Cell"},{"key":"923_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00419-8","volume":"10","author":"J Shen","year":"2022","unstructured":"Shen, J. et al. Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis. Biomark. Res. 10, 72 (2022).","journal-title":"Biomark. Res."},{"key":"923_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.urolonc.2010.04.008","volume":"28","author":"DJ McConkey","year":"2010","unstructured":"McConkey, D.J. et al. Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol. Oncol. 28, 429\u2013440 (2010).","journal-title":"Urol. Oncol."},{"key":"923_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3892\/ol.2020.11569","volume":"20","author":"X Ma","year":"2020","unstructured":"Ma, X. et al. P4HB modulates epithelial-mesenchymal transition and the \u03b2-catenin\/Snail pathway influencing chemoresistance in liver cancer cells. Oncol. Lett. 20, 257\u2013265 (2020).","journal-title":"Oncol. Lett."},{"key":"923_CR18","doi-asserted-by":"publisher","first-page":"107525","DOI":"10.1016\/j.pharmthera.2020.107525","volume":"210","author":"AG Shergalis","year":"2020","unstructured":"Shergalis, A. G. et al. Role of the ERO1-PDI interaction in oxidative protein folding and disease. Pharmacol. Ther. 210, 107525 (2020).","journal-title":"Pharmacol. Ther."},{"key":"923_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/cdd.2016.133","volume":"24","author":"WW Du","year":"2017","unstructured":"Du, W. W. et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 24, 357\u2013370 (2017).","journal-title":"Cell Death Differ."},{"key":"923_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0523-z","volume":"26","author":"C-Y Yu","year":"2019","unstructured":"Yu, C.-Y. & Kuo, H.-C. The emerging roles and functions of circular RNAs and their generation. J. Biomed. Sci. 26, 29 (2019).","journal-title":"J. Biomed. Sci."},{"key":"923_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41419-020-02785-3","volume":"11","author":"L Yin","year":"2020","unstructured":"Yin, L. et al. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3. Cell Death Dis. 11, 562 (2020).","journal-title":"Cell Death Dis."},{"key":"923_CR22","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.18632\/aging.102983","volume":"12","author":"D Zhao","year":"2020","unstructured":"Zhao, D. et al. Survival-associated alternative splicing signatures in non-small cell lung cancer. Aging 12, 5878\u20135893 (2020).","journal-title":"Aging"},{"key":"923_CR23","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/j.cell.2021.07.016","volume":"184","author":"S Satpathy","year":"2021","unstructured":"Satpathy, S. et al. A proteogenomic portrait of lung squamous cell carcinoma. Cell 184, 4348\u20134371.e40 (2021).","journal-title":"Cell"},{"key":"923_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cmet.2022.11.009","volume":"35","author":"OE Olaniru","year":"2023","unstructured":"Olaniru, O. E. et al. Single-cell transcriptomic and spatial landscapes of the developing human pancreas. Cell Metab. 35, 184\u2013199.e5 (2023).","journal-title":"Cell Metab."},{"key":"923_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7150\/ijbs.66913","volume":"18","author":"D Chen","year":"2022","unstructured":"Chen, D. et al. Integrated machine learning and bioinformatic analyses constructed a novel stemness-related classifier to predict prognosis and immunotherapy responses for hepatocellular carcinoma patients. Int. J. Biol. Sci. 18, 360\u2013373 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"923_CR26","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks, J. J. et al. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J. Clin. Epidemiol. 58, 882\u2013893 (2005).","journal-title":"J. Clin. Epidemiol."},{"key":"923_CR27","doi-asserted-by":"publisher","first-page":"711433","DOI":"10.3389\/fimmu.2021.711433","volume":"12","author":"Q Xu","year":"2021","unstructured":"Xu, Q. et al. Landscape of immune microenvironment under immune cell infiltration pattern in breast cancer. Front. Immunol. 12, 711433 (2021).","journal-title":"Front. Immunol."},{"key":"923_CR28","doi-asserted-by":"publisher","first-page":"1137648","DOI":"10.3389\/fendo.2023.1137648","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Quantitative proteomics identified a novel invasion biomarker associated with EMT in pituitary adenomas. Front. Endocrinol. 14, 1137648 (2023).","journal-title":"Front. Endocrinol."},{"key":"923_CR29","doi-asserted-by":"publisher","first-page":"926461","DOI":"10.3389\/fimmu.2022.926461","volume":"13","author":"Z Jiang","year":"2022","unstructured":"Jiang, Z. et al. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment. Front. Immunol. 13, 926461 (2022).","journal-title":"Front. Immunol."},{"key":"923_CR30","doi-asserted-by":"publisher","first-page":"1016081","DOI":"10.3389\/fcvm.2022.1016081","volume":"9","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction. Front. Cardiovasc. Med. 9, 1016081 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"923_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1756-9966-32-101","volume":"32","author":"L Chang","year":"2013","unstructured":"Chang, L. et al. Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity. J. Exp. Clin. Cancer Res. 32, 101 (2013).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"923_CR32","first-page":"685","volume":"37","author":"B-C Jiang","year":"2017","unstructured":"Jiang, B.-C. et al. Promoted interaction of C\/EBP\u03b1 with demethylated cxcr3 gene promoter contributes to neuropathic pain in mice. J. Neurosci. 37, 685\u2013700 (2017).","journal-title":"J. Neurosci."},{"key":"923_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-017-0977-7","volume":"17","author":"M Li","year":"2017","unstructured":"Li, M. et al. Lactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococci. BMC Microbiol. 17, 66 (2017).","journal-title":"BMC Microbiol."},{"key":"923_CR34","doi-asserted-by":"publisher","first-page":"86264","DOI":"10.18632\/oncotarget.21137","volume":"8","author":"K Zhao","year":"2017","unstructured":"Zhao, K. et al. Methylation of microRNA-129-5P modulates nucleus pulposus cell autophagy by targeting Beclin-1 in intervertebral disc degeneration. Oncotarget 8, 86264\u201386276 (2017).","journal-title":"Oncotarget"},{"key":"923_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0595-9","volume":"27","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. Circular RNA circ_0003204 inhibits proliferation, migration and tube formation of endothelial cell in atherosclerosis via miR-370-3p\/TGF\u03b2R2\/phosph-SMAD3 axis. J. Biomed. Sci. 27, 11 (2020).","journal-title":"J. Biomed. Sci."},{"key":"923_CR36","doi-asserted-by":"publisher","first-page":"1141417","DOI":"10.3389\/fonc.2023.1141417","volume":"13","author":"X Hu","year":"2023","unstructured":"Hu, X. et al. Knockdown of SPON2 inhibits the growth of triple-negative breast cancer. Front. Oncol. 13, 1141417 (2023).","journal-title":"Front. Oncol."},{"key":"923_CR37","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.2147\/OTT.S178597","volume":"11","author":"LH Cui","year":"2018","unstructured":"Cui, L. H. et al. lncRNA PCAT6 promotes non-small cell lung cancer cell proliferation, migration and invasion through regulating miR-330-5p. OncoTargets Ther. 11, 7715\u20137724 (2018).","journal-title":"OncoTargets Ther."},{"key":"923_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.omtn.2021.12.035","volume":"27","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner. Mol. Ther. Nucleic Acids 27, 699\u2013717 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"923_CR39","first-page":"3270","volume":"41","author":"Z Ban","year":"2019","unstructured":"Ban, Z. et al. LRG\u20111 enhances the migration of thyroid carcinoma cells through promotion of the epithelial\u2013mesenchymal transition by activating MAPK\/p38 signaling. Oncol. Rep. 41, 3270\u20133280 (2019).","journal-title":"Oncol. Rep."},{"key":"923_CR40","doi-asserted-by":"publisher","first-page":"884362","DOI":"10.3389\/fimmu.2022.884362","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. YAP1 alleviates sepsis-induced acute lung injury via inhibiting ferritinophagy-mediated ferroptosis. Front. Immunol. 13, 884362 (2022).","journal-title":"Front. Immunol."},{"key":"923_CR41","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1038\/s41388-022-02456-x","volume":"41","author":"W Liu","year":"2022","unstructured":"Liu, W. et al. MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3. Oncogene 41, 4606\u20134617 (2022).","journal-title":"Oncogene"},{"key":"923_CR42","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1021\/acs.nanolett.0c04713","volume":"21","author":"J Bian","year":"2021","unstructured":"Bian, J. et al. Modulation of local overactive inflammation via injectable hydrogel microspheres. Nano Lett. 21, 2690\u20132698 (2021).","journal-title":"Nano Lett."},{"key":"923_CR43","doi-asserted-by":"publisher","first-page":"100246","DOI":"10.1016\/j.xpro.2020.100246","volume":"2","author":"G Toda","year":"2020","unstructured":"Toda, G. et al. Preparation and culture of bone marrow-derived macrophages from mice for functional analysis. STAR Protoc. 2, 100246 (2020).","journal-title":"STAR Protoc."},{"key":"923_CR44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/apm.12837","volume":"126","author":"R Cheng","year":"2018","unstructured":"Cheng, R. et al. B7-H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma. Acta Pathol. Microbiol. Immunol. Scand. 126, 396\u2013402 (2018).","journal-title":"Acta Pathol. Microbiol. Immunol. Scand."},{"key":"923_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2019.10.013","volume":"468","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y. & Zhan, H. Communication between EMT and PD-L1 signaling: new insights into tumor immune evasion. Cancer Lett. 468, 72\u201381 (2020).","journal-title":"Cancer Lett."},{"key":"923_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","volume":"17","author":"SC Bonnal","year":"2020","unstructured":"Bonnal, S. C. et al. Roles and mechanisms of alternative splicing in cancer\u2014implications for care. Nat. Rev. Clin. Oncol. 17, 457\u2013474 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"923_CR47","doi-asserted-by":"publisher","first-page":"100728","DOI":"10.1016\/j.drup.2020.100728","volume":"53","author":"R Sciarrillo","year":"2020","unstructured":"Sciarrillo, R. et al. The role of alternative splicing in cancer: from oncogenesis to drug resistance. Drug Resist. Updat. 53, 100728 (2020).","journal-title":"Drug Resist. Updat."},{"key":"923_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/ol.2020.12356","volume":"21","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma. Oncol. Lett. 21, 95 (2021).","journal-title":"Oncol. Lett."},{"key":"923_CR49","doi-asserted-by":"publisher","first-page":"923768","DOI":"10.3389\/fgene.2022.923768","volume":"13","author":"Z Yao","year":"2022","unstructured":"Yao, Z. et al. Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer. Front. Genet. 13, 923768 (2022).","journal-title":"Front. Genet."},{"key":"923_CR50","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1080\/21655979.2021.2003929","volume":"13","author":"B Yi","year":"2022","unstructured":"Yi, B. et al. Circular RNA PLCE1 promotes epithelial mesenchymal transformation, glycolysis in colorectal cancer and M2 polarization of tumor-associated macrophages. Bioengineered 13, 6243\u20136256 (2022).","journal-title":"Bioengineered"},{"key":"923_CR51","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.7150\/thno.101575","volume":"14","author":"M Li","year":"2024","unstructured":"Li, M. et al. SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3\/CCL2\/IL-6 axis and is regulated by VEZF1. Theranostics 14, 6543\u20136559 (2024).","journal-title":"Theranostics"},{"key":"923_CR52","doi-asserted-by":"publisher","first-page":"101051","DOI":"10.1016\/j.tranon.2021.101051","volume":"14","author":"R Suresh","year":"2021","unstructured":"Suresh, R. & Roberto, J. D. The remodelling of actin composition as a hallmark of cancer. Transl. Oncol. 14, 101051 (2021).","journal-title":"Transl. Oncol."},{"key":"923_CR53","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna, C. et al. Macrophage M1\/M2 polarization. Eur. J. Pharmacol. 877, 173090 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"923_CR54","doi-asserted-by":"publisher","first-page":"101751","DOI":"10.1016\/j.xcrm.2024.101751","volume":"5","author":"K Liu","year":"2024","unstructured":"Liu, K. et al. Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy. Cell Rep. Med. 5, 101751 (2024).","journal-title":"Cell Rep. Med."},{"key":"923_CR55","doi-asserted-by":"publisher","first-page":"101512","DOI":"10.1016\/j.xcrm.2024.101512","volume":"5","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy. Cell Rep. Med. 5, 101512 (2024).","journal-title":"Cell Rep. Med."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00923-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00923-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00923-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:04:03Z","timestamp":1761289443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00923-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["923"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-00923-8","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of China Medical University (No. CMUXN2023039).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical"}}],"article-number":"330"}}